SLC2A1 and type 2 diabetes mellitus: The complex interaction between ω-3 fatty acids and T lymphocyte metabolism, including the reduction in GLUT-1 expression and glucose uptake, underscores the potential of ω-3 fatty acids in the management of T2DM, offering both metabolic and immunological therapeutic perspectives for nonobese patients with T2DM.